The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By

Deltalab

Advising Deltalab, a leading Spanish laboratory solutions provider with dedicated manufacturing capacity, on the sale of the company to SCG Packaging Public Company Limited, the largest integrated packaging and paper company in Southeast Asia

Portfolio of 16 European Consumer Healthcare brands from Sanofi

Advising Sanofi, a leading global player in the Consumer Healthcare market, on the divestiture of a portfolio of 16 European Consumer Healthcare brands to STADA, a German pharmaceutical and consumer healthcare company owned by Bain Capital and Cinven

Rights to General, Right Guard and Dry Idea brands

Advised Henkel on its brand divestment program (including the sale of the General, Right Guard and Dry Idea brands)

International Flavors & Fragrances, Inc.’s Fruit Preparations business

Advised International Flavors & Fragrances on the divestiture of its European-based Fruit Preparation business to Frulact Serviços Partilhados, SA

Acacia Pharma Group plc

Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share

Youfoodz Holdings Limited

Advised Youfoodz Holdings Limited, a leading provider of fresh, ready-made meals and other convenience food products, on its initial public offering on the Australian Securities Exchange (ASX)

Cosmetic applications endolysin

Advised Micreos, a fast-growing biotechnology company, on a long-term license agreement with L’Oréal for one of Micreos’ phage-based active ingredients, SA.100

Integrated supplier of preserved and frozen vegetables

Advised ACON Agri Investments S.L., a special purpose vehicle of ACON Investments LLC, on the acquisition of Grupo Alsur, a leading integrated supplier of preserved and frozen vegetables with operations in Spain and Peru

CSM Bakery Solutions

Advised the Ad-Hoc Group of First Lien and Second Lien Lenders on consensual out-of-court amend & extend

Centrifuge and processing equipment business of Koki Holdings Co., Ltd.

Advised Eppendorf AG, a leading family-owned life science company, on the acquisition of the centrifuge and processing equipment business of KKR-owned Koki Holdings Co., Ltd., a manufacturer of power tools and centrifuge and processing equipment

Global rights (excluding North America) to ThermaCare (United Kingdom)

Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the global rights (excluding North America) for ThermaCare, including a dedicated manufacturing facility based in Albany, Georgia, USA, to Angelini Pharma

Daimler's Mercedes-Benz passenger car and private vans distribution operations in Colombia

Advised Inchcape, a leading global independent multi-brand automotive distributor, on its acquisition of the Mercedes-Benz passenger car and private vans distribution operations in Colombia from Daimler Colombia

Nitta Casings and Nitta Casings Canada

Advised Viscofan (BME:VIS), the #1 producer of artificial casings for the meat industry worldwide (>30% market share), on the acquisition of Nitta Casings and Nitta Casings Canada (“NCI” and “NCCI”) one of the leading brands in the production of collagen casings in North America, from Nitta Gelatin (TSE:4977)

New Belgium Brewing

Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of New Belgium Brewing, a leading US independent craft brewery

Grupo Electro Stocks

Advised Apax Partners, a global investment firm, on the sale of Grupo Electro Stocks, a leading Spanish distributor of electrical materials, to the Electrical Wholesale business unit within the Würth Group, a global leader in the distribution of assembling and fastening materials

Lion's Specialty Cheese division

Advised Lion, an Australian subsidiary of Kirin and one of Australasia’s leading food and beverage companies, on the sale of its Specialty Cheese division to Saputo, one of the top ten dairy processors in the world

Four Pillars Gin

Advised Lion, an Australian subsidiary of Kirin, on its acquisition of a strategic stake in Four Pillars Gin, Australia’s leading craft gin distillery

The Laundress Inc.

Advised The Laundress Inc., a laundry and home cleaning products brand, on its sale to Unilever, a British-Dutch consumer goods company

Starpharma Holdings Limited, patented VivaGel BV® product

Advised Starpharma Holdings Limited on a US licensing agreement of its patented VivaGel BV® product with ITF Pharma, a US subsidiary of Italfarmaco S.p.A., a privately held European specialty pharmaceutical company

Storz & Bickel GmbH, related entities and IP

Advised Canopy Growth, a leading diversified cannabis company, on its acquisition of Storz & Bickel, a premium manufacturer of vaporization devices

Restaurant Brands New Zealand Limited

Advised Finaccess Capital, an investment company with a strong presence in the casual dining and quick service restaurant sector, on its 75% partial takeover of Restaurant Brands New Zealand, a corporate franchisee specialising in managing multi-site branded food retail chains (with brands consisting of KFC, Pizza Hut, Taco Bell and Carl’s Jr.)

TeePublic

Advised Redbubble, a global online independent artist community and marketplace, on the acquisition of TeePublic, a similar online platform, and associated A$61 million equity raising

Montserrat Day Hospital Group

Advised ASX-listed Primary Health Care, one of Australia’s leading providers of multi-disciplinary healthcare services, on its acquisition of the Montserrat Day Hospital Group, an owner and operator of day hospital facilities

Frutarom

Advised IFF, a leading innovator of specialty ingredients, on its acquisition of Frutarom, creating a global leader in Taste, Scent and Nutrition

Novartis AG’s 36.5% stake in Consumer Health Joint Venture

Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture